Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Autonomic Dysreflexia in SCI
NCT02298660Phase 4Completed
- Sponsor
- Praxis Spinal Cord Institute
- Start
- Apr 2013
- Primary completion
- Oct 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in neurogenic detrusor overactivity (NDO), sponsored by Praxis Spinal Cord Institute. Started Apr 2013; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
neurogenic detrusor overactivity (NDO)
Beyond the preview
Go deeper on NCT02298660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02298660.